BioPharma Credit PLC (LON:BPCP – Get Free Report) hit a new 52-week high on Wednesday . The stock traded as high as GBX 74 and last traded at GBX 74, with a volume of 71636 shares trading hands. The stock had previously closed at GBX 72.30.
BioPharma Credit Stock Performance
The business has a 50 day moving average of GBX 71.40 and a 200-day moving average of GBX 69.99. The company has a market capitalization of £999.00 million, a P/E ratio of 10.74 and a beta of 0.18.
About BioPharma Credit
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.
Recommended Stories
- Five stocks we like better than BioPharma Credit
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
